Bridging the translational gap: Implementation of multimodal small animal imaging strategies for tumor burden assessment in a co-clinical trial
Open Access
- 8 April 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0207555
Abstract
In designing co-clinical cancer studies, preclinical imaging brings unique challenges that emphasize the gap between man and mouse. Our group is developing quantitative imaging methods for the preclinical arm of a co-clinical trial studying immunotherapy and radiotherapy in a soft tissue sarcoma model. In line with treatment for patients enrolled in the clinical trial SU2C-SARC032, primary mouse sarcomas are imaged with multi-contrast micro-MRI (T1 weighted, T2 weighted, and T1 with contrast) before and after immune checkpoint inhibition and pre-operative radiation therapy. Similar to the patients, after surgery the mice will be screened for lung metastases with micro-CT using respiratory gating. A systems evaluation was undertaken to establish a quantitative baseline for both the MR and micro-CT systems against which others systems might be compared. We have constructed imaging protocols which provide clinically-relevant resolution and contrast in a genetically engineered mouse model of sarcoma. We have employed tools in 3D Slicer for semi-automated segmentation of both MR and micro-CT images to measure tumor volumes efficiently and reliably in a large number of animals. Assessment of tumor burden in the resulting images was precise, repeatable, and reproducible. Furthermore, we have implemented a publicly accessible platform for sharing imaging data collected during the study, as well as protocols, supporting information, and data analyses. In doing so, we aim to improve the clinical relevance of small animal imaging and begin establishing standards for preclinical imaging of tumors from the perspective of a co-clinical trial.Keywords
All Related Versions
Funding Information
- National Cancer Institute (U24 CA220245)
- National Cancer Institute (R01 CA196667)
- National Cancer Institute (1R35CA197616)
This publication has 60 references indexed in Scilit:
- Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft ModelKorean Journal of Radiology, 2013
- Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentationEJNMMI Research, 2013
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseNature, 2012
- Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoringCancer Biology & Therapy, 2011
- The APL Paradigm and the “Co-Clinical Trial” ProjectCancer Discovery, 2011
- Imaging Primary Lung Cancers in Mice to Study Radiation BiologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- In vivosmall-animal imaging using micro-CT and digital subtraction angiographyPhysics in Medicine & Biology, 2008
- Imaging artifacts at 3.0TJournal of Magnetic Resonance Imaging, 2006
- Central brightening due to constructive interference with, without, and despite dielectric resonanceJournal of Magnetic Resonance Imaging, 2005
- Practical cone-beam algorithmJournal of the Optical Society of America A, 1984